Islamabad, August 19, 2014. — The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Intel Corporation announced today a collaboration aimed at improving research and treatment for Parkinson’s disease — a neurodegenerative brain disease second only to Alzheimer’s in worldwide prevalence. The collaboration includes a multiphase research study using a new big data analytics platform thatdetects patterns in participant datacollected from wearable technologiesused to monitor symptoms. This effort is an important step in enabling researchers and physicians to measure progression of the diseaseand to speed progress toward breakthroughs in drug development.
 |
| Data is collected from Parkinson's patients via wearable devices, and housed in an open platform for analysis that may lead to new insights and improvements in care via a new partnership between Intel and the Michael J. Fox Foundation. |
“Nearly 200 years after Parkinson’s disease was first described by Dr. James Parkinson in 1817, we are still subjectively measuring Parkinson’s disease largely the same way doctors did then,” said Todd Sherer, PhD, CEO of The Michael J. Fox Foundation.“Data science, wearable computing and data from other sources hold the potential to transform our ability to capture and objectively measure patients’ actual experience of disease, with unprecedented implications for Parkinson’s drug development, diagnosis and treatment.”
 |
| Anonymous patient data is aggregated and analyzed for new insight into Parkinson's disease via a new partnership between Intel and the Michael J. Fox Foundation. |
“The variability in Parkinson’s symptoms creates unique challenges in monitoring progression of the disease,” said Diane Bryant, senior vice president and general manager of Intel’s Data Center Group. “Emerging technologies can not only create a new paradigm for measurement of Parkinson’s, but as more data is made available to the medical community, it may also point to currently unidentified features of the disease that could lead to new areas of research.”
No comments:
Post a Comment